The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study
Open accessAbstract
OBJECTIVES: To assess and compare the effects of candesartan or lisinopril, or both, on blood pressure and urinary albumin excretion in patients with microalbuminuria, hypertension, and type 2 diabetes. DESIGN: Prospective, randomised, parallel group, double blind study with four week placebo run in period and 12 weeks' monotherapy with candesartan or lisinopril followed by 12 weeks' monotherapy or combination treatment. SETTING: Tertiary hospitals and primary care centres in four countries (37 centres). PARTICIPANTS: 199 patients aged 30-75 years. INTERVENTIONS: Candesartan 16 mg once daily, lisinopril 20 mg once daily. MAIN OUTCOME MEASURES: Blood pressure and urinary albumin:creatinine ratio. RESULTS: At 12 weeks mean (95% confidence interval) reductions in diastolic blood pressure were 9.5 mm Hg (7.7 mm Hg to 11.2 mm Hg, P<0.001) and 9.7 mm Hg (7.9 mm Hg to 11.5 mm Hg, P<0.001), respectively, and in urinary albumin:creatinine ratio were 30% (15% to 42%, P<0.001) and 46% (35% to 56%, P<0.001) for candesartan and lisinopril, respectively. At 24 weeks the mean reduction in diastolic blood pressure with combination treatment (16.3 mm Hg, 13.6 mm Hg to 18.9 mm Hg, P<0. 001) was significantly greater than that with candesartan (10.4 mm Hg, 7.7 mm Hg to 13.1 mm Hg, P<0.001) or lisinopril (mean 10.7 mm Hg, 8.0 mm Hg to 13.5 mm Hg, P<0.001). Furthermore, the reduction in urinary albumin:creatinine ratio with combination treatment (50%, 36% to 61%, P<0.001) was greater than with candesartan (24%, 0% to 43%, P=0.05) and lisinopril (39%, 20% to 54%, P<0.001). All treatments were generally well tolerated. CONCLUSION: Candesartan 16 mg once daily is as effective as lisinopril 20 mg once daily in reducing blood pressure and microalbuminuria in hypertensive patients with type 2 diabetes. Combination treatment is well tolerated and more effective in reducing blood pressure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
(2000) · PubMed · Cited by 2,095
Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
Chaturvedi, N., Sjolie, A.-K., Stephenson, J. M., Abrahamian, H., Keipes, M., Castellarin, A., Rogulja-Pepeonik, Z., & Fuller, J. H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06209-0 · Cited by 743
Cha, M., Eastwaad, S., Hartan, R., Maher, D., Olkin, I., Pitkin, R., Rennie, D., Schulz, K. F., Simel, D. L., & Straup, D. F. (1996) · Cited by 737
Pathogenesis, prevention, and treatment of diabetic nephropathy
Cooper, M. E. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01346-4 · Cited by 560
Self-citationPrevention of diabetic renal disease with special reference to microalbuminuria
Mogensen, C. E., Keane, W. F., Bennett, P. H., Striker, G. E., Jerums, G., Parving, H.-H., Passa, P., Steffes, M. W., & Viberti, G. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91747-0 · Cited by 543
Self-citationChaturvedi, N. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10244-0 · Cited by 518
British Hypertension Society guidelines for hypertension management 1999: summary
Ramsay, L. E., Williams, B., Johnston, G. D., MacGregor, G. A., Poston, L., Potter, J. F., Poulter, N. R., & Russell, G. (1999) · BMJ · doi:10.1136/bmj.319.7210.630 · Cited by 373
Hollenberg, N. K., Fisher, N. D. L., & Price, D. A. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.387 · Cited by 336
Marre, M., Jeunemaitre, X., Gallois, Y., Rodier, M., Chatellier, G., Sert, C., Dusselier, L., Kahal, Z., Chaillous, L., Halimi, S., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119321 · Cited by 326
CANZANELLO, V. J., & SHEPS, S. G. (1998) · Cardiology in Review · doi:10.1097/00045415-199809000-00009 · Cited by 277
Russo, D., Pisani, A., Balletta, M. M., De Nicola, L., Savino, F. A., Andreucci, M., & Minutolo, R. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70416-6 · Cited by 243
Azizi, M., Chatellier, G., Guyene, T.-T., Murieta-Geoffroy, D., & Ménard, J. (1995) · Circulation · doi:10.1161/01.cir.92.4.825 · Cited by 217
Hamroff, G., Katz, S. D., Mancini, D., Blaufarb, I., Bijou, R., Patel, R., Jondeau, G., Olivari, M.-T., Thomas, S., & Le Jemtel, T. H. (1999) · Circulation · doi:10.1161/01.cir.99.8.990 · Cited by 212
Angiotensin receptor antagonists: focus on losartan
Johnston, C. I. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92411-6 · Cited by 211
Mathiesen, E. R., Hommel, E., Hansen, H. P., Smidt, U. M., & Parving, H.-H. (1999) · BMJ · doi:10.1136/bmj.319.7201.24 · Cited by 192
Parving, H.-H., Jacobsen, P., Tarnow, L., Rossing, P., Lecerf, L., Poirier, O., & Cambien, F. (1996) · BMJ · doi:10.1136/bmj.313.7057.591 · Cited by 185
Safety of the combination of valsartan and benazepril in patients with chronic renal disease
Ruilope, L. M., Aldigier, J. C., Ponticelli, C., Oddou-Stock, P., Botteri, F., & Mann, J. F. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018010-00013 · Cited by 179
AGARDH, C. ‐., García‐Puig, J., Charbonnel, B. H., Angelkort, B., & Barnett, A. H. (1996) · PubMed · Cited by 139
Allen, T. J., Cao, Z., Youssef, S., Hulthén, U. L., & Cooper, M. E. (1997) · Diabetes · doi:10.2337/diacare.46.10.1612 · Cited by 135
Self-citationNephropathy in type 2 diabetes
Ritz, E. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00411.x · Cited by 118
Combination ACE Inhibitor and Angiotensin II Receptor Antagonist Therapy in Diabetic Nephropathy
Hebert, L. A., Falkenhain, M. E., Nahman, N. S., Cosio, F. G., & O’Dorisio, T. M. (1999) · American Journal of Nephrology · doi:10.1159/000013417 · Cited by 110
Angiotensin-Converting Enzyme Genotype in Children and Coronary Events in Their Grandparents
Badenhop, R. F., Wang, X. L., & Wilcken, D. E. L. (1995) · Circulation · doi:10.1161/01.cir.91.6.1655 · Cited by 67
Prevention of Diabetic Renal Disease with Special Reference to Microalbuminuria
Mogensen, C. E., Keane, W. F., Bennett, P. H., Jerums, G., Parving, H., Passa, P., Steffes, M. W., Striker, G. E., & Viberti, G. C. (1996) · Springer eBooks · doi:10.1007/978-1-4757-6749-0_53 · Cited by 49
Self-citationGoa, K. L., Haria, M., & Wilde, M. I. (1997) · Drugs · doi:10.2165/00003495-199753060-00010 · Cited by 42
Renal Effects of Angiotensin I-Receptor Blockade and Angiotensin Convertase Inhibition in Man
Schmitt, F., Natov, S. N., Martinez, F., Lacour, B., & Hannedouche, T. P. (1996) · Clinical Science · doi:10.1042/cs0900205 · Cited by 23
Demeilliers, B., Jover, B. F., & Mimran, A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00017 · Cited by 22
Cited by
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Metadata
- Authors
- Mogensen, C. E., Neldam, S., Tikkanen, I., Oren, S., Viskoper, R., Watts, R. W., & Cooper, M. E.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-12-09
- Volume
- 321
- Issue
- 7274
- Pages
- 1440-1444
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2084343172
- Cited by
- 1,037
- References
- 33
- FWCI
- 49.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.